EQO is a biotechnology company that specializes in utilizing eRNA (environmental RNA) and eDNA (environmental DNA) technologies to monitor and analyze biodiversity. The company's core offerings revolve around providing comprehensive biodiversity profiles, diagnosing threats to ecosystems, and enabling initiatives for rejuvenating global ecosystems.
EQO's proprietary biotechnology allows it to capture and analyze genetic material from environmental samples, enabling detailed assessments of the species present in a given area. The company's eRNA technology is particularly powerful as it provides a real-time snapshot of the biodiversity, complementing the historical data obtained through eDNA analysis. This dual approach, combining eRNA and eDNA, is touted as the gold standard in biodiversity assessment.
EQO's services have been instrumental in various environmental conservation efforts. The company has successfully mitigated invasive species infestations, protected endangered species, facilitated superfund site restoration, and safeguarded water and power resources for municipalities. Additionally, EQO's technology has been utilized for early detection of fecal contamination, identifying taste and odor issues, and providing biosecurity threat intervention tools to federal agencies.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.